Abstract:The APOE gene harboring the ε2 and ε4 alleles encoded by minor alleles of rs7412 and rs429358 single nucleotide polymorphisms (SNPs), respectively, is one of the most studied genes in humans. Despite that, the problem of whether the associations between these alleles and the late‐onset Alzheimer’s disease (referred to as AD) are due to these alleles themselves remains controversial. This problem is complicated by an inherent heterogeneity in genetic predisposition to AD, which is common for complex diseases in late life. We used a comprehensive, two‐stage strategy to gain insights into a more homogeneous genetic architecture of AD in subjects of European ancestry in the TOMM40‐APOE‐APOC1 region, emphasizing the role of the ε4 allele. First, we examined differences in linkage disequilibrium (LD) patterns in AD‐affected and unaffected subjects who carry or do not carry the ε4 or ε2 allele to prioritize SNP pairs according to the LD differences. Second, rs429358 and SNPs from the top pair were selected to construct compound genotypes and associate them with AD. The discovery analyses used a mega‐sample of 2,673 AD‐affected and 16,246 cognitively normal subjects from four independent studies. The landmark Alzheimer's Disease Genetics Consortium initiative cohort (3,662 AD‐cases and 1,541 controls) was used for validation. The top LD difference between the most unfavorable AD‐affected ε2‐free sample and the most favorable AD‐ and ε4‐free sample was for rs2075650 (TOMM40) and rs12721046 (APOC1) SNPs, Δr=77.6% (p<10‐100). The meta‐analysis results showed the exceptionally high risk of AD for carriers of the full minor allele homozygote comprised of rs429358, rs2075650, and rs12721046 SNPs, odds ratio=18.1, p=1.96×10‐77. This risk was 4.37‐fold (p=1.34×10‐3) higher than that for carriers of two copies of the ε4 alleles who do not have minor alleles of rs2075650 and rs12721046. This study provides compelling evidence that the strongest genetic predisposition to AD in the APOE region is credited to a haplotype comprised of the ε4 allele and TOMM40 (rs2075650) and APOC1 (rs12721046) minor alleles, but not to the ε4 allele itself. This more homogeneous polygenic profile is promising for assessing subjects at an exceptionally high risk of AD.

TOMM40-APOE chimera linking Alzheimer's highest risk genes: a new pathway for mitochondria regulation and APOE4 pathogenesis

Genetic Contributions of APOE Ε4 and TOMM40 Rs2075650 to Mitochondrial Dysmorphia

TOMM40 and APOE variants synergistically increase the risk of Alzheimer’s disease in a Chinese population

<i>TOMM40</i>and<i>APOE</i>variants synergistically increase the risk of Alzheimer's disease in a Chinese population

Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk

Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity

The ε4‐bearing TOMM40‐APOE‐APOC1 haplotype but not the ε4 allele confers an exceptionally high risk of Alzheimer’s disease

APOE, TOMM40, and sex interactions on neural network connectivity

APOE4 impairs the microglial response in Alzheimer's disease by inducing TGF-mediated checkpoints

The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation

Cholesterol and Matrisome Pathways Dysregulated in Human APOE Ε4 Glia

The APOE isoforms differentially shape the transcriptomic and epigenomic landscapes of human microglia in a xenotransplantation model of Alzheimer's disease

APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFβ-mediated checkpoints

Cholesterol and matrisome pathways dysregulated in astrocytes and microglia

The Contributions of the Endolysosomal Compartment and Autophagy to APOEɛ4 Allele-Mediated Increase in Alzheimer's Disease Risk

APOEε4 and risk of Alzheimer's disease – time to move forward

The Contributions of the Endolysosomal Compartment and Autophagy to APOE ɛ4 Allele-Mediated Increase in Alzheimer's Disease Risk

TOMM40 Genetic Variants Cause Neuroinflammation in Alzheimer's Disease

APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer’s disease and age-matched non-demented brains

A multi‐hit hypothesis for an APOE4‐dependent pathophysiological state

Identification of a specific APOE transcript and functional elements associated with Alzheimer's disease